DWD GER Week ended 31 Jul 2026

Weekly Investor Report

Morgan Stanley · Financial Services · Capital Markets

Open interactive chart View report data
Latest close 184.2 EUR
-2.0% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 12.7% above the Trend Line and sits at 78.2% of its 52-week range. The latest completed week returned -2.0%, after a -1.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 46/100.

Setup score 72 out of 100
Latest Close 184.2 EUR 31 Jul 2026
1W Return -2.0% latest completed week
4W Return -1.3% short-term follow-through
12W Return 12.6% quarterly tape
Trend Breadth 88.5% 46 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
What is working
  • The trend backdrop is active with a 16-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
  • Latest weekly return ranks in the weaker part of its sector group.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.0% Latest completed week; four-week move -1.3%. Indicator stack 94/61 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 60.69% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 46/100 15 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 12.7% above the Trend Line and sits at 78.2% of its 52-week range. The latest completed week returned -2.0%, after a -1.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9812-week average 0.84

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.98Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.3% over four weeks, 12.6% over 12 weeks, and 56.5% over one year. The current trend has remained active for 16 consecutive weeks.

Performance by holding period

1W-2.0%
4W-1.3%
12W12.6%
26W22.0%
52W56.5%
Active trend streak16 weeks
Active weeks in one year46
Trend breadth88.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.73Latest activity-pressure read.
Pressure change-30.0%Four-week change in activity pressure.
Leadership15.12Latest relative-leadership reading.
RS change-23.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 64% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength54/100Blend of value, momentum, and quality. Underlying universe rank 47; rank 1 is best.
Value51/100Relative valuation strength. Underlying universe rank 50; rank 1 is best.
Quality49/100Profitability and accounting quality. Underlying universe rank 52; rank 1 is best.
Momentum51/100Medium-term price momentum. Underlying universe rank 50; rank 1 is best.
Growth54/100Revenue and earnings growth. Underlying universe rank 47; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
17.6x
Price divided by trailing earnings.
Price / sales
4.5x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-3.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-31.5%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.9%
Cash dividends relative to market value.
Buyback yield
2.0%
Net share repurchases relative to market value.
Shareholder yield
3.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment46/100

Weighted news tone is neutral across 15 relevant articles.

0 positive · 12 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-9.1%Distance below the 52-week high.
13-week volatility2.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher16 of 2610 weeks finished lower.
Best week+6.9%Week of 17 Apr.
Worst week-6.4%Week of 13 Feb.
Latest week-2.0%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains11
Flat weeks0
Modest losses7
Sharp losses3
Recent vol2.9%13-week weekly-return volatility.
Base vol3.1%52-week weekly-return volatility.
Up/down split36/16Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape75/100

Trend, activity pressure, participation, and risk combine to a 75/100 tape read.

 Indicator analysis87/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.98; 2 reversal markers Next-Week ExpectancyPositive 60.69%

Next-week expectancy is positive with a 60.69% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 20 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment46/100

Weighted news tone is neutral across 15 relevant articles.

Morgan Stanley cuts Salzgitter stock price target on valuation By Investing.com Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026184.2 EUR-2.0%163.4 EUR112.1 EUR0.7315.122.6KOn
24 Jul 2026187.9 EUR0.2%162.3 EUR111.4 EUR0.9620.78983On
17 Jul 2026187.6 EUR-2.8%161.0 EUR110.7 EUR1.0722.886.2KOn
10 Jul 2026193.1 EUR3.5%159.7 EUR110.0 EUR1.0626.34842On
3 Jul 2026186.6 EUR-0.3%158.3 EUR109.2 EUR1.0419.783.2KOn
26 Jun 2026187.1 EUR-4.7%157.1 EUR108.4 EUR1.0026.39747On
19 Jun 2026196.4 EUR5.2%155.7 EUR107.7 EUR1.0332.15226On
12 Jun 2026186.7 EUR0.2%153.8 EUR106.9 EUR1.0128.68177On
5 Jun 2026186.4 EUR4.8%152.2 EUR106.1 EUR1.0829.02336On
29 May 2026177.9 EUR2.2%150.5 EUR105.4 EUR1.0222.621.6KOn
22 May 2026174.1 EUR4.5%149.3 EUR104.7 EUR0.9022.111.9KOn
15 May 2026166.6 EUR1.8%148.1 EUR104.0 EUR0.6722.385.6KOn
8 May 2026163.6 EUR1.5%147.0 EUR103.4 EUR0.4919.111.8KOn
1 May 2026161.1 EUR1.0%145.9 EUR102.8 EUR0.3118.45914On
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.